Robert Dickey

Robert Dickey possesses extensive experience in financial leadership and corporate development within the life sciences sector. Currently serving as Chief Financial Officer and a member of the Board of Directors at SFA Therapeutics, Robert also holds the position of Director of Finance at Vitruviae and Chief Corporate Development Officer at BCI LifeSciences LLC. Previous roles include Managing Director at Foresite Advisors, CFO positions at Sharp Edge Labs and South Rampart Pharma, as well as a board member and Audit Committee Chairman at Emmaus Life Sciences, Inc. Robert's background includes a notable tenure as CFO at Motif Bio plc, a company focused on developing novel antibiotics. Robert Dickey earned an MBA in Finance from The Wharton School and a BA in Economics from Princeton University.